Clinical Pediatric Pneumonia Score in Critically Ill Children
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02139384
Recruitment Status :
(The study was withdrawn due to inability to enroll patients in a timely fashion.)
The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 21 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
critically ill children admitted the the LLU PICU with acute respiratory failure with suspected community-acquired pneumonia
All intubated pediatric patients
Age 1 day to 21 years
Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
Have received antibiotics for less than 12 hours
Have been intubated for less than 24 hours
Patients must be English or Spanish speaking for consent purposes.
Patients who have received antibiotics for greater than 12 hours
Patients who have been intubated for greater than 24 hours
Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage